Pendopharm, a division of Pharmascience Inc., has announced an existing anti-inflammatory gout drug as a new repurposed treatment. In August 2021, Health Canada issued a […]

Millions of people have thyroid glands that don’t make enough thyroid hormone to meet their body’s needs. Most people with hypothyroidism and Hashimoto’s Thyroiditis who […]

Several clinical trials, including a large trial with 1,500 test subjects, indicate that the fluvoxamine may help COVID-19 patients in the early stages of the […]

On June 16, 2021, Taro Canada announced the introduction of its budesonide inhalation suspension, a generic version of Pulmicort Respules (budesonide) inhalation suspension by AstraZeneca. […]

According to a 2018 report published by the CDC (Centers for Disease Control and Prevention), more than 87% of adults ages 65+ take at least […]